Health insurance benefits of Kadcyla Inj 100mg & 160mg will be registered
The health insurance benefits of ‘Kadcyla Inj(trastuzumab emtansine),’ a Roche Korea’s treatment for breast cancer, will be applied today.
The Ministry of Health and Welfare(Minister Neung-Hoo Park) amended and issued the ‘Drug Insurance Benefits List and Upper Limit Price Table’ on the 2nd.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.